Capital International, Inc. Crispr Therapeutics Ag Transaction History

Capital International, Inc.

$7.23 Billion
Q2 2024

A detailed history of Capital International, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital International, Inc. holds 102,178 shares of CRSP stock, worth $5.15 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

102,178

Previous 91,661 11.47%

Holding current value

$5.15 Million

Previous $6.25 Million 11.67%

% of portfolio

0.08%

Previous 0.09%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $538,154 - $717,049	10,517 Added 11.47%	102,178 $5.52 Million
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $1.4 Million - $2.05 Million	23,007 Added 33.51%	91,661 $6.25 Million
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $13,169 - $24,613	341 Added 0.5%	68,654 $4.3 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $139,029 - $180,717	3,063 Added 4.69%	68,313 $3.1 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $182,356 - $284,295	4,195 Added 6.87%	65,250 $3.66 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $484,005 - $662,496	11,805 Added 23.97%	61,055 $2.76 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $154,369 - $258,674	-3,939 Reduced 7.41%	49,250 $2 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $584,360 - $801,271	9,564 Added 21.92%	53,189 $3.48 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $321,804 - $549,590	7,444 Added 20.57%	43,625 $2.65 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $811,892 - $1.21 Million	-15,264 Reduced 29.67%	36,181 $2.27 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $160,295 - $254,520	2,287 Added 4.65%	51,445 $3.9 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $453,362 - $644,416	-4,114 Reduced 7.72%	49,158 $5.5 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $1.76 Million - $2.83 Million	-17,463 Reduced 24.69%	53,272 $8.62 Million
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $5.3 Million - $10.1 Million	-47,912 Reduced 40.38%	70,735 $8.62 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $547,093 - $1.19 Million	6,867 Added 6.14%	118,647 $18.2 Million
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $8.77 Million - $11.2 Million	111,780 New	111,780 $9.35 Million

Others Institutions Holding CRSP

# of Institutions

504

Shares Held

57.1M

Call Options Held

1.74M

Put Options Held

1.84M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.93B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Crispr Therapeutics Ag Transaction History